| 113 Major differences in the response of primary human blood cells to IFN-b JA Zula, Y Xu, RM Ransohoff, JW Jacobberger, GR Stark Cytokine 43 (3), 263-263, 2008 | | 2008 |
| 113 Major differences in the response of primary human blood cells to IFN-β AHH van Boxel-Dezaire, JA Zula, Y Xu, RM Ransohoff, JW Jacobberger, ... Cytokine 3 (43), 263, 2008 | | 2008 |
| 58. IDENTIFYING POTENTIAL ENVIRONMENTAL INFLUENCES ON CLINICAL COMORBIDITIES OF SCHIZOPHRENIA THROUGH INTEGRATION OF ELECTRONIC HEALTH DATA AND GENETICS T Vessels, N Strayer, K Choi, T Morley, H Lee, J Smoller, Y Xu, D Ruderfer European Neuropsychopharmacology 51, e71-e72, 2021 | | 2021 |
| 63. IDENTIFYING MODIFIABLE COMORBIDITIES OF SCHIZOPHRENIA BY INTEGRATING ELECTRONIC HEALTH RECORDS AND POLYGENIC RISK T Vessels, N Strayer, K Choi, H Lee, S Zhang, L Han, T Morley, ... European Neuropsychopharmacology 75, S89-S90, 2023 | | 2023 |
| A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis DB Johnson, WJ McDonnell, PI Gonzalez-Ericsson, RN Al-Rohil, ... Nature medicine 25 (8), 1243-1250, 2019 | 157 | 2019 |
| A novel laminin-induced lysophosphatidic acid autocrine loop in the migration of ovarian S Sengupta, YJ Xiao, Y Xu FASEB JOURNAL 17 (9), 1570-+, 2003 | | 2003 |
| A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic data sets C Vlasschaert, T Mack, JB Heimlich, A Niroula, MM Uddin, J Weinstock, ... Blood, The Journal of the American Society of Hematology 141 (18), 2214-2223, 2023 | 59 | 2023 |
| Abstract A1-24: DNA methylation sequencing of prostate tumors: Possible molecular mechanisms for cancer aggressiveness JM Bhasin, L Matkin, MG Taylor, BH Lee, C Magi-Galluzi, EA Klein, B Hu, ... Cancer Research 75 (22_Supplement_1), A1-24-A1-24, 2015 | | 2015 |
| Abstract P1-08-34: Peripheral immunity predicts therapeutic outcomes in breast cancer patients ML Axelrod, Y Wang, Y Xu, CA Bejan, X Sun, PI Gonzalez-Ericsson, ... Cancer Research 82 (4_Supplement), P1-08-34-P1-08-34, 2022 | | 2022 |
| Advanced molecular characterization of severe autoimmune toxicities associated with checkpoint inhibitor therapies. JM Balko, DY Wang, Y Wang, R Al-Rohil, M Compton, JA Sosman, ... Cancer Research 77, 2017 | | 2017 |
| Atherosclerosis and Lipoproteins-Atherosclerosis Susceptibility Loci Identified From a Strain Intercross of Apolipoprotein E-Deficient Mice via a High-Density Genome Scan JD Smith, JM Bhasin, J Baglione, M Settle, Y Xu, J Barnard Arteriosclerosis Thrombosis and Vascular Biology 26 (3), 597-603, 2006 | | 2006 |
| Atherosclerosis Susceptibility Loci Identified from a Strain Intercross of Apolipoprotein E–Deficient Mice via a High-Density Genome Scan JD Smith, JM Bhasin, J Baglione, M Settle, Y Xu, J Barnard Arteriosclerosis, thrombosis, and vascular biology 26 (3), 597-603, 2006 | 54 | 2006 |
| Breast-cancer stromal cells with TP53 mutations and nodal metastases A Patocs, L Zhang, Y Xu, F Weber, T Caldes, GL Mutter, P Platzer, C Eng New England Journal of Medicine 357 (25), 2543-2551, 2007 | 366 | 2007 |
| Clonal Hematopoiesis and Inflammation in the Vasculature (CHIVE), a Prospective, Longitudinal Clonal Hematopoiesis Cohort and Biorepository J Heimlich, M Shannon, S Olson, AJ Silver, A Debevec, Z Copeland, ... Blood 142, 5594, 2023 | | 2023 |
| Clonal Hematopoiesis and Inflammation in the VasculaturE (CHIVE): a prospective, longitudinal clonal hematopoiesis cohort and biorepository ML Shannon, JB Heimlich, S Olson, A Debevec, Z Copeland, A Kishtagari, ... Blood Advances, 2024 | | 2024 |
| Clonal Hematopoiesis and Inflammation in the VasculaturE (CHIVE): a prospective, longitudinal cohort and biorepository ML Shannon, JB Heimlich, S Olson, A Debevec, Z Copeland, A Kishtagari, ... Blood Advances, bloodadvances. 2023011510, 2024 | | 2024 |
| Clonal hematopoiesis is associated with incident severe aortic stenosis MA Raddatz, AJ Silver, E Farber-Eger, Y Xu, QS Wells, MR Savona, ... Circulation 144 (Suppl_1), A9334-A9334, 2021 | 3 | 2021 |
| Cost-effective and scalable clonal hematopoiesis assay provides insight into clonal dynamics T Mack, C Vlasschaert, K von Beck, AJ Silver, JB Heimlich, H Poisner, ... The Journal of Molecular Diagnostics, 2024 | 5 | 2024 |
| DNMT3A R882H exhibits greater inflammatory potential than R882C in primary hematopoietic stem and progenitor cell knock-in model and population data AJ Silver, DJ Brown, C Vlasschaert, P Bhat, F Puddu, JC Van Amburg, ... Blood 142, 815, 2023 | 2 | 2023 |
| Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk A Kishtagari, MAW Khan, Y Li, C Vlasschaert, N Marneni, AJ Silver, ... Blood Cancer Journal 14 (1), 6, 2024 | 2 | 2024 |